Our study not only revealed a causal relationship between pyruvate metabolism and BC risk, but also found that ADH1B, ACSS2, ACACB, ADH1A, ALDH2, and ADH1C takes place a major part in the development of BC in the molecular mechanisms related to pyruvate metabolism, and identified some potential targeted small molecule drugs. This evidence concerns the gene ADH1A and breast cancer.